Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine vs. Pantoprazole for Aspirin-Induced Ulcer Prevention
NCT00843063Phase 4Completed
- Sponsor
- Ruttonjee Hospital
- Start
- Aug 2004
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of famotidine in peptic ulcer disease (PUD), sponsored by Ruttonjee Hospital. Started Aug 2004; status: completed.
02
Drugs
famotidine
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT00843063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843063.